This is an audio transcript of the Behind the Money podcast episode: ‘Not everyone will win in Trump’s M&A revival’ Michela ...

"To my mind, all of this public input and engagement made our work sharper and helped us really set priorities and focus on ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

The US Federal Trade Commission has prepared a lawsuit against tractor giant Deere & Co. alleging the company’s agricultural ...

Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.

A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.

Independent contractors and gig workers who organize or collectively bargain are shielded from antitrust liability under a ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

While Greystar maintains it has been proactive in improving fee disclosures and promoting transparency, the company noted the ...

Republican Rep. Ben Cline (Va.) is continuing a legislative push to strip the Federal Trade Commission of its role overseeing ...